GENEiQ

GeneIQ is a boutique molecular diagnostics laboratory focused on providing a multi-faceted testing portfolio focusing on Molecular Infectious Disease (Respiratory, Urinary and COVID-19,). The GeneIQ pharmacogenomic platform can determine how a patient's genetic makeup will affect response to numerous medications prescribed in a number of specialties including addiction, cardiology, diabetes, gastroenterology, neurology, oncology, orthopedics, pain management, psychiatry, and rheumatology. With 27 different genes and 10 test menus available for analysis, GeneIQ provides the most robust pharmacogenetic offering to clinicians. Additionally GENEiQ offers Cancer Genomic testing through Nexgen Sequencing to predict hereditary Cancer predisposition. We combine the expertise of an outstanding laboratory team combined with a nationally renowned scientific team. Our robust process and state of the art instrument methodolgy ensures expedited delivery of results and the highest level of patient support.GeneIQ: the right medication, the first time!